Stockscreener 앱 받기
19.86
2.63%
-0.49
시간 외 거래:
19.83
-0.03
-0.15%
전일 마감가:
$20.35
열려 있는:
$19.7
하루 거래량:
1.36M
Relative Volume:
1.17
시가총액:
$2.11B
수익:
$247.00M
순이익/손실:
$-249.00M
주가수익비율:
-6.4272
EPS:
-3.09
순현금흐름:
$-267.00M
1주 성능:
-0.33%
1개월 성능:
+48.43%
6개월 성능:
+117.27%
1년 성능:
+27.35%
1일 변동 폭
$19.69
$20.54
1주일 범위
$18.32
$22.11
52주 변동 폭
$6.50
$22.11
Arcus Biosciences Inc Stock (RCUS) Company Profile
명칭
Arcus Biosciences Inc
전화
(510) 694-6200
주소
3928 POINT EDEN WAY, HAYWARD, CA
RCUS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCUS
Arcus Biosciences Inc
|
19.83 | 2.20B | 247.00M | -249.00M | -267.00M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-10-21 | 개시 | H.C. Wainwright | Neutral |
| 2024-10-08 | 개시 | Wells Fargo | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Neutral |
| 2022-10-11 | 개시 | Morgan Stanley | Overweight |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2020-11-24 | 개시 | Berenberg | Buy |
| 2020-11-23 | 개시 | Evercore ISI | Outperform |
| 2020-04-03 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-09-27 | 개시 | Mizuho | Buy |
| 2019-05-24 | 재개 | Citigroup | Buy |
| 2018-10-09 | 개시 | Wedbush | Outperform |
| 2018-04-09 | 개시 | Citigroup | Buy |
| 2018-04-09 | 개시 | Goldman | Neutral |
| 2018-04-09 | 개시 | Leerink Partners | Outperform |
모두보기
Arcus Biosciences Inc 주식(RCUS)의 최신 뉴스
Arcus Biosciences Completes Successful Stock Offering - MSN
Does Arcus Biosciences Inc. show high probability of rebound2025 Fundamental Recap & AI Based Buy and Sell Signals - newser.com
How Arcus Biosciences Inc. stock reacts to job market data2025 Market Outlook & Weekly High Momentum Picks - newser.com
Latham & Watkins Advises Arcus Biosciences in US$250 Million Public Offering of Common Stock - Legal Desire Media and Insights
Arcus Biosciences Completes Public Offering of Common Stock - TradingView
Is Arcus Biosciences Inc. stock a buy on dipsJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Automated trading signals detected on Arcus Biosciences Inc.Trade Volume Report & Consistent Profit Focused Trading Strategies - newser.com
Mizuho Raises Price Target on Arcus Biosciences to $47 From $45, Keeps Outperform Rating - MarketScreener
Why Arcus Biosciences Inc. stock is rated strong buyTrade Exit Summary & Verified Stock Trade Ideas - newser.com
What is the fair value estimate for Arcus Biosciences Inc. stock in 2025Trade Analysis Report & Expert-Curated Trade Recommendations - newser.com
Visual analytics tools that track Arcus Biosciences Inc. performanceBuy Signal & Weekly Breakout Watchlists - newser.com
Arcus Biosciences, Inc. (RCUS) Stock Forecasts - Yahoo! Finance Canada
Price action breakdown for Arcus Biosciences Inc.2025 Top Decliners & AI Driven Price Predictions - newser.com
What dividend safety score for Arcus Biosciences Inc. stockJuly 2025 Market Mood & Weekly High Potential Stock Alerts - newser.com
Risk adjusted return profile for Arcus Biosciences Inc. analyzedWeekly Investment Summary & AI Forecasted Entry and Exit Points - newser.com
Should you hold or exit Arcus Biosciences Inc. nowJuly 2025 Market Mood & Low Risk Investment Opportunities - newser.com
Why Arcus Biosciences Inc. stock appears on watchlistsQuarterly Trade Summary & Verified Entry Point Signals - newser.com
How moving averages guide Arcus Biosciences Inc. trading2025 Big Picture & Breakout Confirmation Trade Signals - newser.com
Using AI based signals to follow Arcus Biosciences Inc.2025 EndofYear Setup & Risk Managed Investment Signals - newser.com
Reversal indicators forming on Arcus Biosciences Inc. stockJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
Arcus Biosciences announces launch of public offering - MSN
Arcus Biosciences prices $250M offering - MSN
Arcus Biosciences (NYSE:RCUS) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
Analyzing recovery setups for Arcus Biosciences Inc. investorsWeekly Investment Recap & High Accuracy Trade Signal Alerts - newser.com
Arcus Biosciences (NYSE:RCUS) Shares Gap Down on Insider Selling - MarketBeat
Arcus Biosciences, Inc. (NYSE:RCUS) Just Reported, And Analysts Assigned A US$29.60 Price Target - simplywall.st
Arcus Biosciences, Inc. (NYSE:RCUS) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
FY2025 EPS Estimates for RCUS Increased by Analyst - MarketBeat
Wedbush Increases Earnings Estimates for Arcus Biosciences - MarketBeat
HC Wainwright Has Positive Forecast for RCUS FY2025 Earnings - MarketBeat
Arcus Biosciences (NYSE:RCUS) President Juan Jaen Sells 19,019 Shares - MarketBeat
Insider Selling: Arcus Biosciences (NYSE:RCUS) President Sells 77,840 Shares of Stock - MarketBeat
Arcus Biosciences stock falls after pricing $250 million public offering By Investing.com - Investing.com Nigeria
Arcus Biosciences launches public offering of common stock By Investing.com - Investing.com Australia
Arcus Biosciences stock falls after pricing $250 million public offering - Investing.com
Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG), TransMedics Group (TMDX) and Arcus Biosciences (RCUS) - The Globe and Mail
Arcus Biosciences (RCUS) Announces Pricing Details for Recent Of - GuruFocus
Arcus Biosciences falls after $250 mln stock sale - TradingView
Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Beats Revenue Estimates - MSN
Arcus Biosciences Inc (RCUS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):